IndustryCompany release

Zentek reports C$15.2M six-month profit on impairment reversal; cash rises to C$13.6M

Zentek Ltd. (ZTEKF) · Tue 17 Nov 2026

The Canadian company's interim results show earnings driven by a C$19.7M non-operating reversal, while sales stayed negligible and operating costs increased.

Zentek Ltd. has published unaudited interim financial statements for the quarter and six months ended 30 September 2026, approved by its board on 16 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Company's press release (SEC filing): Zentek Ltd. ↗

Article written by VigiEye from the official source (Zentek Ltd.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →